16.51
Janux Therapeutics Inc (JANX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
175.03%
10.27
|
3.733 | - | 10.00 | - |
| Research and Development |
15.59%
30.99
|
26.81 | - | - | 34.66 |
| Operating Income/Loss |
7.37%
-31.69
|
-34.21 | -42.40 | -35.25 | -45.12 |
| Nonoperating Income/Loss |
1.36%
9.718
|
9.852 | 10.46 | 10.94 | 11.26 |
| Net Income/Loss |
9.81%
-21.97
|
-24.36 | -31.95 | -24.31 | -33.86 |
| Basic Average Shares |
0.43%
62.94
|
62.67 | 0.0602 | 62.02 | 61.90 |
| Diluted Average Shares |
0.43%
62.94
|
62.67 | 0.0602 | 62.02 | 61.90 |
| Basic Earnings Per Share |
10.26%
-0.35
|
-0.39 | -0.51 | -0.39 | -0.55 |
| Diluted Earnings Per Share |
10.26%
-0.35
|
-0.39 | -0.51 | -0.39 | -0.55 |
大文字化:
|
ボリューム (24 時間):